H. Ledermann

651 total citations
16 papers, 463 citations indexed

About

H. Ledermann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H. Ledermann has authored 16 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H. Ledermann's work include Pharmacogenetics and Drug Metabolism (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Epilepsy research and treatment (2 papers). H. Ledermann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Epilepsy research and treatment (2 papers). H. Ledermann collaborates with scholars based in Germany, Sweden and United Kingdom. H. Ledermann's co-authors include Enrico Haupt, Wolfgang Köpcke, Hans Lithell, Bengt Vessby, Inga‐Britt Gustafsson, Ann‐Margret Östlund‐Lindqvist, Kristoffer Hellsing, B. Vessby, Jonas Boberg and Graeme I. Bell and has published in prestigious journals such as Diabetes, Psychopharmacology and Atherosclerosis.

In The Last Decade

H. Ledermann

15 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Ledermann Germany	10	186	152	135	107	97	16	463
C Berne Sweden	11	89 0.5×	180 1.2×	65 0.5×	66 0.6×	104 1.1×	19	440
Etty Osher Israel	14	66 0.4×	150 1.0×	113 0.8×	60 0.6×	131 1.4×	19	601
Michihiro Matsuki Japan	12	251 1.3×	317 2.1×	180 1.3×	73 0.7×	123 1.3×	39	667
Simona Moffa Italy	12	229 1.2×	297 2.0×	183 1.4×	95 0.9×	92 0.9×	24	549
G. De Mattia Italy	11	109 0.6×	216 1.4×	117 0.9×	67 0.6×	199 2.1×	21	627
S. Khilnani United States	9	105 0.6×	125 0.8×	97 0.7×	117 1.1×	146 1.5×	14	512
O Küchel Czechia	9	142 0.8×	295 1.9×	121 0.9×	46 0.4×	81 0.8×	31	695
Ruben Pipek United States	8	123 0.7×	173 1.1×	214 1.6×	38 0.4×	202 2.1×	11	533
George B. Kudolo United States	15	64 0.3×	114 0.8×	66 0.5×	21 0.2×	53 0.5×	28	536
Conn Jw United States	14	201 1.1×	331 2.2×	136 1.0×	24 0.2×	72 0.7×	28	607

Countries citing papers authored by H. Ledermann

Since Specialization

Citations

This map shows the geographic impact of H. Ledermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ledermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ledermann more than expected).

Fields of papers citing papers by H. Ledermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Ledermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ledermann. The network helps show where H. Ledermann may publish in the future.

Co-authorship network of co-authors of H. Ledermann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Ledermann. A scholar is included among the top collaborators of H. Ledermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Ledermann. H. Ledermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Seyfried, Christoph A., et al.. (2008). Pharmakokinetik des β-Rezeptorenblockers Metipranolol bei Patienten mit Leberzirrhose. DMW - Deutsche Medizinische Wochenschrift. 107(1). 21–26.

Haupt, Enrico, H. Ledermann, & Wolfgang Köpcke. (2005). Benfotiamine in the treatment of diabetic polyneuropathy a three-week randomized, controlled pilot study (BEDIP Study). International Journal of Clinical Pharmacology and Therapeutics. 43(2). 71–77. 120 indexed citations

Netzer, Peter, P.U. Reber, Stephan M. Wildi, et al.. (2002). Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?. Alimentary Pharmacology & Therapeutics. 16(1). 119–127. 22 indexed citations

Ledermann, H., et al.. (1997). Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes. 46(3). 528–535. 27 indexed citations

Kaisaki, Pamela J., Stephan Menzel, Tom H. Lindner, et al.. (1997). Mutations in the Hepatocyte Nuclear Factor-1α Gene in MODY and Early-Onset NIDDM: Evidence for a Mutational Hotspot in Exon 4. Diabetes. 46(3). 528–535. 108 indexed citations

Ledermann, H. & G Höxter. (1994). [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].. PubMed. 112(32). 467–70. 4 indexed citations

Rosenkranz, Bernd, H. Ledermann, & Jürgen C. Frölich. (1986). Interaction Between Nifedipine and Atenolol. Journal of Cardiovascular Pharmacology. 8(5). 943–949. 13 indexed citations

Ledermann, H., et al.. (1985). Variability in the pharmacokinetics of atenolol and metoprolol.. PubMed. 35(5). 848–51. 7 indexed citations

Whiting, B., A. W. Kelman, DJ Sumner, W S Hillis, & H. Ledermann. (1982). Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers.. British Journal of Clinical Pharmacology. 13(4). 529–532. 3 indexed citations

10.

Vessby, B., Hans Lithell, & H. Ledermann. (1982). Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate. Atherosclerosis. 44(1). 113–118. 34 indexed citations

11.

Ledermann, H. & B. Kaufmann. (1981). Comparative Pharmacokinetics of 400 mg Bezafibrate after a Single Oral Administration of a New Slow-Release Preparation and the Currently Available Commercial Form. Journal of International Medical Research. 9(6). 516–520. 11 indexed citations

12.

Kjellin, K.G., et al.. (1981). Effects of Bezafibrate on Low HDL-Cholesterol in Patients with Ischaemic Cerebrovascular Disease: A Pilot Study. Journal of International Medical Research. 9(5). 319–323. 2 indexed citations

13.

Dick, Travis B., et al.. (1981). Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemia. Current Medical Research and Opinion. 7(8). 489–502. 13 indexed citations

14.

Vessby, Bengt, Hans Lithell, Kristoffer Hellsing, et al.. (1980). Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters. Atherosclerosis. 37(2). 257–269. 74 indexed citations

15.

Andersson, Karl‐Erik, B Johansson, H. Ledermann, H. von Schenck, & Jan I. Thorell. (1977). The effects of digoxin and β‐methyldigoxin on the heart rate of decompensated patients with atrial fibrillation. European Journal of Clinical Investigation. 7(1). 3–6. 8 indexed citations

16.

Holmberg, Gunnar, et al.. (1977). Sedative properties of doxepin in comparison with diazepam. Psychopharmacology. 54(2). 165–169. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact